Chemotherapy of hematological malignancies in patients with COVID-19

Chemotherapy of hematological malignancies in patients with COVID-19

In the era of COVID-19, the chemotherapy of patients with hematological malignancies has become the cornerstone in hematology. Secondary immunodeficiency as a result of hemoblastosis, predisposes to a more severe course of coronavirus infection, and specific antitumor treatment only exacerbates pati...

Full description

Bibliographic Details
Main Authors: T. S. Chudnova, E. A. Baryakh, M. S. Litvinenko, T. N. Tolstykh, O. L. Kochneva, E. Y. Grishina, E. N. Misyurina, K. V. Yatskov, E. I. Zhelnova, Y. Y. Polyakov, K. V. Kaluzhskaya
Format: Article
Language:Russian
Published: ABV-press 2022-04-01
Series:Онкогематология
Subjects:
covid-19
chemotherapy
acute leukemia
hodgkin lymphoma
anaplastic large cell lymphoma
richter’s syndrome
Online Access:https://oncohematology.abvpress.ru/ongm/article/view/543

Internet

https://oncohematology.abvpress.ru/ongm/article/view/543

Similar Items